Anyone can have eczema, though CDC data shows that it’s disproportionately diagnosed in women. This complex condition is strongly linked to allergies, asthma, and other autoimmune issues. Common ...

The Cigna Group (NYSE: CI) is one of the best inexpensive stocks to buy according to hedge funds. On August 29, Phothera ...

Dermatologist highlights cosmeceutical products useful in the management of acne, atopic dermatitis, and melasma.

Besides mosquito bites, other causes of itchy bumps on your skin may include hives, other bug bites like flea bites, and ...

Amgen (AMGN) stock in focus as the company and Kyowa Kirin (KYKOF) report Phase 3 data showing their atopic dermatitis drug, ...

As children return to school, common skin conditions that were previously under control may flare up once again, thanks to a ...

Data from the late-stage trial of amlitelimab weren’t as strong as the results seen in Phase 2, adding to doubts about a drug ...

Shares in French drugmaker Sanofi fell more than 10% on Thursday, wiping nearly $13 billion off its market value, after ...

Sanofi (SNY) stock drops after Phase 3 trial results for amlitelimab, its experimental therapy for eczema, disappointed ...

Amlitelimab showed efficacy in skin clearance and disease severity compared to placebo in a phase 3 study with adolescent and ...

Imagine a child with eczema who scratches a patch of irritated skin. A tiny opening forms, invisible to the eye. Into that ...

Amlitelimab use in patients with moderate to severe AD was associated with significant improvements in COAs for up to 52 weeks.